Although it is an undeniable fact that dopaminergic therapy has greatly improved the quality of life and prognosis of patients with Parkinson's disease, various and serious adverse events correlated to dopaminergic drugs are not uncommon. Among these, those of neuropsychological and psychopathological nature are of particular importance, being capable of causing an upheaval in the basic personality of the patient. To this regard, the authors report the actual words of a patient himself that are far more convincing that any considerations we may express. In our opinion, the overwhelming impact of dopaminergic treatment on the psychopathological and neuropsychological equilibrium of all parkinsonian patients should unfailingly be carefully evaluated and pondered, particularly in the early onset forms of the disease.